We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Continuous Glucose Monitoring System Offers Advanced Diabetes Management

By HospiMedica International staff writers
Posted on 29 Jun 2010
An innovative continuous glucose monitoring (CGM) system detects high and low glucose fluctuations that can lead to dangerous health complications, which often go undetected with traditional A1C and glucose meter readings.

The Medtronic iPro2 Professional CGM system uses a tiny, disposable glucose sensor to record as many as 288 readings over a 24-hour period. More...
The system includes the glucose sensor and a small data recorder that automatically records the glucose information. The patients wear the lightweight, watertight device while going about their normal daily activities, before returning it to their physicians' office for evaluation. Once returned, the glucose information stored on the device is uploaded (using a proprietary docking station) to the CareLink iPro software, a fully integrated, web-based platform that stores the data from iPro2 Professional CGM and simplifies data evaluation.

Attending physicians can then remotely access the software, using any computer with an internet connection. Reports containing continuous glucose information are well organized and capture important glucose trends, such as hyperglycemic and hypoglycemic episodes, that could affect treatment decisions. The reports are also useful for educating and motivating patients to implement changes in their diabetes management, after viewing the effects that specific foods, exercise, stress, and medications have on their glucose levels. The Medtronic iPro2 Professional CGM is a product of Medtronic (Minneapolis, MN, USA), and has received the Conformité Européenne (CE) Marking of approval.

"It's never been easier to reveal previously undetected high and low glucose excursions and understand their causes. This information is helpful for making better treatment decisions to improve patients' lives,” said Francine Kaufman, M.D., chief medical officer and vice president of global medical, clinical, and health affairs of the Medtronic diabetes business. "Moreover, iPro2 Professional CGM is quick to implement and provides reports that physicians can use to educate patients on the therapy and lifestyle changes they can make to improve their health and quality of life.”

Related Links:

Medtronic



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.